➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Dow
Medtronic
Merck
Harvard Business School

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

CHOLESTYRAMINE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cholestyramine and what is the scope of patent protection?

Cholestyramine is the generic ingredient in eight branded drugs marketed by Parke Davis, Ajanta Pharma Ltd, Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Zydus Pharms, Teva Pharms, Allied, Upsher Smith Labs, Bristol Myers, and Apothecon, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Eight suppliers are listed for this compound.

Drug Prices for CHOLESTYRAMINE

See drug prices for CHOLESTYRAMINE

Recent Clinical Trials for CHOLESTYRAMINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Seoul National University HospitalN/A
EA Pharma Co., Ltd.Phase 2
Yokohama City UniversityPhase 2

See all CHOLESTYRAMINE clinical trials

Pharmacology for CHOLESTYRAMINE

US Patents and Regulatory Information for CHOLESTYRAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 077203-001 Aug 26, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Bristol Myers QUESTRAN LIGHT cholestyramine POWDER;ORAL 019669-001 Dec 5, 1988 DISCN Yes No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs PREVALITE cholestyramine POWDER;ORAL 073263-002 Oct 30, 1997 AB RX No No   Start Trial   Start Trial   Start Trial
Teva CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074348-001 May 28, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers QUESTRAN cholestyramine POWDER;ORAL 016640-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc CHOLESTYRAMINE cholestyramine POWDER;ORAL 074554-001 Oct 2, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Harvard Business School
Dow
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.